STOCK TITAN
  1. Home
  2. Sec-filings
  3. LFCR
  4. [Form 4] Lifecore Biomedical, Inc. Insider Trading Activity

[Form 4] Lifecore Biomedical, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock LFCR logo
Lifecore Biomedical Inc

NASDAQ:LFCR

LFCR Rankings

#5358 Ranked by Market Cap
N/A Ranked by Dividends

LFCR Latest News

Jul 17, 2025
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 17, 2025
Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer
Jun 12, 2025
Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale
May 27, 2025
Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer
Apr 22, 2025
Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference

LFCR Latest SEC Filings

Jul 17, 2025
[Form 4] Lifecore Biomedical, Inc. Insider Trading Activity
Jul 17, 2025
[Form 4] Lifecore Biomedical, Inc. Insider Trading Activity
Jul 17, 2025
[Form 4] Lifecore Biomedical, Inc. Insider Trading Activity
Jul 17, 2025
[Form 4] Lifecore Biomedical, Inc. Insider Trading Activity
Jul 17, 2025
[Form 4] Lifecore Biomedical, Inc. Insider Trading Activity

LFCR Stock Data

301.76M
36.38M
4.52%
73.6%
6.45%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
CHASKA